K2M Group Holdings Inc  

(Public, NASDAQ:KTWO)   Watch this stock  
Find more results for K2M, Inc
+0.15 (0.73%)
After Hours: 20.64 0.00 (0.00%)
Mar 2, 5:07PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 19.19 - 21.05
52 week 12.31 - 23.63
Open 20.50
Vol / Avg. 0.00/232,855.00
Mkt cap 817.35M
P/E     -
Div/yield     -
EPS -1.93
Shares 39.46M
Beta     -
Inst. own 34%
Mar 24, 2015
K2M Group Holdings Inc at Canaccord Genuity Musculoskeletal Conference - 2:30PM EDT - Add to calendar
Mar 11, 2015
K2M Group Holdings Inc at Barclays Healthcare Conference - 9:00AM EDT - Add to calendar
Mar 4, 2015
K2M Group Holdings Inc at Cowen Health Care Conference - 11:20AM EST - Add to calendar
Jan 12, 2015
Preliminary Q4 2014 K2M Group Holdings Inc Earnings Release
Dec 3, 2014
K2M Group Holdings Inc at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -33.89% -24.06%
Operating margin -27.10% -28.51%
EBITD margin - -3.36%
Return on average assets -20.29% -12.71%
Return on average equity -23.94% -46.97%
Employees 414 -
CDP Score - -


751 Miller Dr SE
LEESBURG, VA 20175-8993
United States - Map
+1-703-7773155 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


K2M Group Holdings, Inc. (K2M) is a global medical device company focused on designing, developing and commercializing spine technologies and techniques. Its spine products are used by spine surgeons to treat some of the most difficult and challenging spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. Its products consist of implants, disposables and instruments which are marketed and sold primarily to hospitals for use by spine surgeons. In addition to its current product portfolio, it continue to invest in the design, development and commercialization of new solutions for unmet clinical needs in the complex spine and MIS markets by its product development process. The Company market and sell its products in the United States and 28 other countries. The Company�s products include Complex Spine, Minimally Invasive Spine and Degenerative Spine. The Company�s technologies include MESA, Rail 4D, Deformity Cricket, SERENGETI, RAVINE, EVEREST and tifix.

Officers and directors

Daniel A Pelak Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Eric D. Major President, Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
Gregory S. Cole CPA Chief Financial Officer
Age: 44
Bio & Compensation  - Reuters
Kostuik P. John Chief Medical Officer, Director
Age: 76
Bio & Compensation  - Reuters
Brett P. Brodnax Director
Age: 49
Bio & Compensation  - Reuters
Carlos A. Ferrer Director
Age: 57
Bio & Compensation  - Reuters
Paul B. Queally Director
Age: 50
Bio & Compensation  - Reuters
Sean M. Traynor Director
Bio & Compensation  - Reuters
Raymond A. Ranelli Independent Director
Age: 66
Bio & Compensation  - Reuters